United States · Markets & Finance · The Wall Street Journal

Germany’s Merck to Buy U.K. Biotech Silence Therapeutics for $1.3 Billion

Published by The Wall Street Journal · United States 9 h ago

Merck said it is offering $20 in cash for each American depositary share for Nasdaq-listed Silence Therapeutics, more than double the target’s closing price as of Friday.

Read the full article on The Wall Street Journal Sign in to save

MediaNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.wsj.com)

Also worth reading

CNBC

Women may be at greater risk of AI job losses. Telephone switch operators and PCs show why

Business Insider

Germany’s Merck to Buy U.K. Biotech Silence Therapeutics for $1.3 Billion

Share

Also worth reading

Women may be at greater risk of AI job losses. Telephone switch operators and PCs show why

AI could eat Big Law's billable hours. Cooley's boss says bring it on.

Trump Defends Russia Sanctions Waiver as Rift With Ukraine Deepens

Made an ‘honest’ mistake with crypto taxes? New bill offers way out

How Boston Dynamics is turning robots into a real business

Strategy Buys $22M in Bitcoin, Buys Back $193M of STRC